Nomoto H et al. |
A case of osteomalacia due to deranged mineral balance caused by saccharated ferric oxide and short-bowel syndrome: A case report. |
2017 |
Medicine (Baltimore) |
pmid:28953654
|
Deng Y et al. |
Efficacy of Intravenous Iron Sucrose in Hemodialysis Patients with Restless Legs Syndrome (RLS): A Randomized, Placebo-Controlled Study. |
2017 |
Med. Sci. Monit. |
pmid:28285317
|
Derman R et al. |
A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia. |
2017 |
Am. J. Hematol. |
pmid:28052413
|
Lee T et al. |
Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. |
2017 |
Gut |
pmid:26848182
|
Faber F et al. |
Host-mediated sugar oxidation promotes post-antibiotic pathogen expansion. |
2016 |
Nature |
pmid:27309805
|
Tiwari P et al. |
Preventive effects of butyric acid, nicotinamide, calcium glucarate alone or in combination during the 7, 12-dimethylbenz (a) anthracene induced mouse skin tumorigenesis via modulation of K-Ras-PI3K-AKTpathway and associated micro RNAs. |
2016 |
Biochimie |
pmid:26655363
|
Fell LH et al. |
Impact of individual intravenous iron preparations on the differentiation of monocytes towards macrophages and dendritic cells. |
2016 |
Nephrol. Dial. Transplant. |
pmid:27190361
|
Song D et al. |
AMD-like retinopathy associated with intravenous iron. |
2016 |
Exp. Eye Res. |
pmid:27565570
|
Gemici C et al. |
Is there any role of intravenous iron for the treatment of anemia in cancer? |
2016 |
BMC Cancer |
pmid:27542823
|
Zager RA et al. |
Combined iron sucrose and protoporphyrin treatment protects against ischemic and toxin-mediated acute renal failure. |
2016 |
Kidney Int. |
pmid:27165818
|
Montano-Pedroso JC et al. |
Postoperative intravenously administered iron sucrose versus postoperative orally administered iron to treat post-bariatric abdominoplasty anaemia (ISAPA): the study protocol for a randomised controlled trial. |
2016 |
Trials |
pmid:27068478
|
Han YM et al. |
Comparison of the Efficacies of Parenteral Iron Sucrose and Oral Iron Sulfate for Anemic Patients with Inflammatory Bowel Disease in Korea. |
2016 |
Gut Liver |
pmid:27021505
|
Barbieri C et al. |
Performance of a Predictive Model for Long-Term Hemoglobin Response to Darbepoetin and Iron Administration in a Large Cohort of Hemodialysis Patients. |
2016 |
PLoS ONE |
pmid:26939055
|
Bitsi S et al. |
Profound hyperglycemia in knockout mutant mice identifies novel function for POU4F2/Brn-3b in regulating metabolic processes. |
2016 |
Am. J. Physiol. Endocrinol. Metab. |
pmid:26670484
|
Airy M et al. |
Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients. |
2015 |
Nephrol. Dial. Transplant. |
pmid:26311216
|
Minami D et al. |
Downregulation of TBXAS1 in an iron-induced malignant mesothelioma model. |
2015 |
Cancer Sci. |
pmid:26211743
|
Ren X et al. |
Effect of Intravenous Iron Supplementation on Acute Mountain Sickness: A Preliminary Randomized Controlled Study. |
2015 |
Med. Sci. Monit. |
pmid:26175087
|
Agarwal R et al. |
A randomized trial of intravenous and oral iron in chronic kidney disease. |
2015 |
Kidney Int. |
pmid:26083656
|
Connor JR et al. |
Comparative evaluation of nephrotoxicity and management by macrophages of intravenous pharmaceutical iron formulations. |
2015 |
PLoS ONE |
pmid:25973894
|
Bhandari S et al. |
A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients. |
2015 |
Nephrol. Dial. Transplant. |
pmid:25925701
|
Toblli JE et al. |
Cardiovascular outcomes of intravenous iron in perspective of clinical trials and the use of different iron preparations. |
2015 |
Int. J. Cardiol. |
pmid:25838213
|
Dai P et al. |
Triple Recycling Processes Impact Systemic and Local Bioavailability of Orally Administered Flavonoids. |
2015 |
AAPS J |
pmid:25762448
|
Toblli JE et al. |
Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron. |
2015 |
Heart Lung Circ |
pmid:25666998
|
Shiue E et al. |
Improving product yields on D-glucose in Escherichia coli via knockout of pgi and zwf and feeding of supplemental carbon sources. |
2015 |
Biotechnol. Bioeng. |
pmid:25258165
|
Tiwari P et al. |
Combinatorial chemopreventive effect of butyric acid, nicotinamide and calcium glucarate against the 7,12-dimethylbenz(a)anthracene induced mouse skin tumorigenesis attained by enhancing the induction of intrinsic apoptotic events. |
2015 |
Chem. Biol. Interact. |
pmid:25478867
|
Barot BS et al. |
Physicochemical and structural characterization of iron-sucrose formulations: a comparative study. |
2014 |
Pharm Dev Technol |
pmid:23701359
|
Wang Y et al. |
Hepatoprotective effects of kombucha tea: identification of functional strains and quantification of functional components. |
2014 |
J. Sci. Food Agric. |
pmid:23716136
|
Almilaji A et al. |
Regulation of the voltage gated K channel Kv1.3 by recombinant human klotho protein. |
2014 |
Kidney Blood Press. Res. |
pmid:25571875
|
Sasaki Y et al. |
Hepcidin production in response to iron is controlled by monocyte-derived humoral factors. |
2014 |
Int. J. Hematol. |
pmid:24293278
|
Raman S et al. |
Evolution-guided optimization of biosynthetic pathways. |
2014 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:25453111
|
Lu QY et al. |
Overestimation of flavonoid aglycones as a result of the ex vivo deconjugation of glucuronides by the tissue β-glucuronidase. |
2014 |
J Pharm Biomed Anal |
pmid:24176739
|
Beguin Y and Jaspers A |
Iron sucrose - characteristics, efficacy and regulatory aspects of an established treatment of iron deficiency and iron-deficiency anemia in a broad range of therapeutic areas. |
2014 |
Expert Opin Pharmacother |
pmid:25186219
|
Price E et al. |
A prospective randomized wait list control trial of intravenous iron sucrose in older adults with unexplained anemia and serum ferritin 20-200 ng/mL. |
2014 |
Blood Cells Mol. Dis. |
pmid:25065855
|
Kuo KL et al. |
Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD. |
2014 |
J. Am. Soc. Nephrol. |
pmid:24722448
|
Macdougall IC et al. |
A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD. |
2014 |
Clin J Am Soc Nephrol |
pmid:24458078
|
Contreras C et al. |
Comparative study of the oral absorption of microencapsulated ferric saccharate and ferrous sulfate in humans. |
2014 |
Eur J Nutr |
pmid:23892521
|
Corwin HL and Napolitano LM |
Anemia in the critically ill: do we need to live with it?*. |
2014 |
Crit. Care Med. |
pmid:25126804
|
Pieracci FM et al. |
A multicenter, randomized clinical trial of IV iron supplementation for anemia of traumatic critical illness*. |
2014 |
Crit. Care Med. |
pmid:24797376
|
Hetzel D et al. |
A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy. |
2014 |
Am. J. Hematol. |
pmid:24639149
|
Perelló MF et al. |
Intravenous ferrous sucrose versus placebo in addition to oral iron therapy for the treatment of severe postpartum anaemia: a randomised controlled trial. |
2014 |
BJOG |
pmid:24423186
|
Toyokuni S |
Iron overload as a major targetable pathogenesis of asbestos-induced mesothelial carcinogenesis. |
2014 |
Redox Rep. |
pmid:24257681
|
Onken JE et al. |
Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial. |
2014 |
Nephrol. Dial. Transplant. |
pmid:23963731
|
Shah RB et al. |
Pharmaceutical characterization and thermodynamic stability assessment of a colloidal iron drug product: iron sucrose. |
2014 |
Int J Pharm |
pmid:24440404
|
Tiwari P and Gupta KP |
Modulation of miR-203 and its regulators as a function of time during the development of 7, 12 dimethylbenz [a] anthracene induced mouse skin tumors in presence or absence of the antitumor agents. |
2014 |
Toxicol. Appl. Pharmacol. |
pmid:24792773
|
Elford P et al. |
Biodistribution and predictive hepatic gene expression of intravenous iron sucrose. |
2013 Nov-Dec |
J Pharmacol Toxicol Methods |
pmid:23624021
|
Soufras GD et al. |
Fatal anaphylactic reaction to iron sucrose in pregnancy: iron-induced Kounis syndrome? |
2013 Nov-Dec |
Indian J Pharmacol |
pmid:24347784
|
Mishra A et al. |
Fatal anaphylactic reaction to iron sucrose in pregnancy. |
2013 Jan-Feb |
Indian J Pharmacol |
pmid:23543624
|
Palmer K et al. |
Review of available intravenous iron preparations in hemodialysis. |
2013 Apr-Jun |
CANNT J |
pmid:24069699
|
Froessler B et al. |
Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: a randomized trial. |
2013 |
J. Matern. Fetal. Neonatal. Med. |
pmid:23130909
|
Bhattacharya S et al. |
The prophylactic role of D-saccharic acid-1,4-lactone against hyperglycemia-induced hepatic apoptosis via inhibition of both extrinsic and intrinsic pathways in diabetic rats. |
2013 |
Food Funct |
pmid:23138840
|